do with covais that after getting the ox jab but also it reduces the number of people who have actually even asymptomatic by around 2 thirds. comments from the british health minister there well earlier we spoke to paul or hunter he's a professor of medicine at the university of east anglia specializing in infectious diseases and epidemiology we asked him about the significance of these new findings there's no doubt that the if you have the vaccine and it stops you actually getting infected that it will stop you as an individual spreading that infection on but they crucial thing that you've got to remember is that it only does that about 2 thirds of the time so there is still a substantial proportion of people who can still after the vaccine get the infection and potentially spread it on and couple of weeks ago we published a paper looking at the available data then which is still a political and we the our conclusion was that although yes it will reach to go a long way to reducing transmission it won't be sufficient in itself and indeed no vaccine will be sufficient in themselves to re

do with covais that after getting your job but also it reduces the number of people who have actual even a symptomatically by around 2 thirds. see some of the other developments in the pandemic the world economic forum has again postponed its 2021 meeting due to the pandemic the business summit plans to meet in singapore this august instead of the swiss resort of balls a t.v. ad by airline ryanair has been banned as irresponsible by the u.k. advertising standards agency it says the slogan jab and go could lead people to corona virus restrictions and as we reported u.k. researchers say one dose of the pfizer biotech back same gives about 90 percent protection from govan 1000 after 21 days their findings or based on an analysis of israel's vaccination program. well the technology being used in the scene from. her and others also promises to be a powerful new weapon in the fight against another disease cancer as today marks world cancer day we take a closer look at the new approach that uses an anti cancer treatment tailor made for each patient and uses so called memory r.n.a. could be a ga

with covais that after getting your job but also it reduces the number of people who have actually even a symptomatically by around 2 thirds. good news indeed but will this be enough to stop community transmission of the virus earlier we spoke to paul r. hunter he's a professor of medicine at the university of east anglia specializing in infectious diseases and epidemiology and we asked him about the significance of these new findings there's no doubt that the if you have the vaccine and it stops you actually getting infected then it will stop you as an individual spreading that infection on but the crucial thing that you've got to remember is that it only does that about 2 thirds of the time so there is still a substantial proportion of people who can still after the vaccine get the infection and potentially spread it on and couple of weeks ago we published a paper looking at the available data then which is still a political and we did our conclusion was that although yes it will reach do go a long way to reducing transmission it won't be sufficient in itself and indeed no vaccine wil

with covais that after getting the ox jab but also it reduces the number of people who have caved it actual even a symptomatically by around 2 thirds are more tonight i'm joined by paul hunter he is a professor in medicine at the university of east anglia specializing in infectious disease and epidemics doctors good to have you on the program so we're talking about a back a vaccine that protects against code 19 and prevent spreading the corona virus this sounds almost too good to be true is it. well i think it is yes to a certain extent i mean there's no doubt that the if you have the vaccine and it stops you actually getting infected then it will stop us an individual spreading that infection on but the crucial thing that you've got to remember is that it only does that about 2 thirds of the cake time so there is still a substantial proportion of people who can still after the vaccine get the infection and potentially spread it on. a couple of weeks ago we published a paper looking at the available data then which is still a political and we the our conclusion was that although yes

as europe continues to struggle with covais divakar seen shortages that it's really the e.u. drugs regulated to fast track the evaluation of rushes that sputnik the job. u.k. food banks are inundated with pleas for help as a growing poverty crisis sees the most vulnerable having to choose between a think oh he take. some of the die live as vulnerable people let's face it. there's too many people behind there's too many people who really really struggle thank you much hard decision do you have a lot of do i have a mate who can do what happened he took. time off to 27 years imus and founder jeff bezos stepped down as chief they.

with covais that after getting york's job but also it reduces the number of people who have carried it at all even a symptomatically by around 2 thirds. now the technology being used in that vaccine and others also promises to become a powerful new weapon in the fight against a mother disease cancer as today marks world cancer day we take a closer look at the new approach that uses an anti cancer treatment tailor made for each patient it uses so called memory r.n.a. and that could be a game changer for cancer sufferers. a customized vaccine created for an individual patients particular tumor fast effective and with few side effects that's the promise of a new m.r. and a technology in the fight against cancer. malignant tumors can slip past the body's defenses for years with camouflage so clever that the immune system doesn't notice the invader before it is too weak to keep the cancer cells at bay allowing the tumor to grow on the hindered. typical treatment involves surgery followed by chemotherapy to destroy any left over cells companies to fix in a dr cat change the biology of this d

with covais that after getting your job but also it reduces the number of people who have actually even a symptomatically by around 2 thirds. good news indeed but will this be enough to stop community transmission of the virus earlier we spoke to par our hunter he is a professor of medicine at the university of east anglia specializing in infectious diseases and epidemiology we asked him about the significance of these new findings there's no doubt that the if you have the vaccine and it stops you actually getting infected then it will stop you as an individual spreading that infection on but the crucial thing that you've got to remember is that it only does that about 2 thirds of the time so there is still a substantial proportion of people who can still after the vaccine get the infection and potentially spread it on and couple of weeks ago we published a paper looking at the available data then which is still a political and we the our conclusion was that although yes it will reach do go a long way to reducing transmission it won't be sufficient in itself and indeed no vaccine will b